Small-cap stocks have become one of 2026’s standout stories, with the Russell 2000 up over 21% YTD, its best start to the ...

Sandisk has sold off sharply, but I view this as a potential dip-buying opportunity given strong AI and memory market ...

Shares of memory and AI-related stocks fell premarket on Wednesday after stock index futures were lower as U.S.-Iran truce ...

Stryker stock looks undervalued with a 13% discount to fair value, a strong EPS growth outlook, and dividend potential. Click ...

ASE Technology (ASX) ramps AI-driven chip packaging as the sector rebounds, but a 60x+ P/E prices in perfection.

Growth stocks hit fragile valuation highs after years of multiple expansion. Here's what investors need to know.

Robert Half is upgraded to “Buy” as labor market conditions show signs of bottoming and sequential business improvement ...

I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation ...

Crane NXT (CXT) stock is a sell: weak earnings quality, high leverage, shrinking DTT margins, and acquisition dilution.

Coherent weathers AI infrastructure selloff with record backlog to 2028, expanding InP moat and growth in optics.

Kura Oncology is positioning ziftomenib (KOMZIFTI) as a combination backbone in AML, not just a relapsed/refractory ...

Amphastar Pharmaceuticals (AMPH) stock dips after an FDA warning letter over manufacturing violations at a California ...